People without a secure job contract can reduce their risk of premature death by 20 percent if they gain permanent employment, a study from Karolinska Institutet published in The Journal of Epidemiology and Community reports.
HIV cell therapy biotech Addimmune to go public via SPAC merger; WHO names new Covid-19 ‘variant of interest’
Addimmune, a biotech that is working on a cell therapy for HIV, announced Wednesday that it plans to merge with 10X Capital Venture’s SPAC to become
August 11, 2023